Deltarasin was the first small molecule effectively targeting the spatial organization of Ras by competing for the farnesyl-binding pocket of PDEδ and thereby resulting in a reduced proliferation of oncogenic KRas-dependent pancreatic ductal adenocarcinoma cells13. Here, KRAS is linked to pancreatic ductal adenocarcinoma.